{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:22:45Z","timestamp":1789176165151,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000692","name":"Royal College of Surgeons of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.02190","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T07:10:08Z","timestamp":1568877008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa"],"prefix":"10.3389","volume":"10","author":[{"given":"Imran","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia G.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Nubile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Mastropasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder S.","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1099\/jmm.0.000209","article-title":"Novel engineered cationic antimicrobial peptides display broad-spectrum activity against Francisella tularensis, Yersinia pestis and Burkholderia pseudomallei.","volume":"65","author":"Abdelbaqi","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/s0161-6420(00)00179-2","article-title":"Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.","volume":"107","author":"Alexandrakis","year":"2000","journal-title":"Ophthalmology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/AAC.03147-14","article-title":"Optimizing the clinical use of vancomycin.","volume":"60","author":"Alvarez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40123-018-0141-y","article-title":"Antibiotic resistance rates by geographic region among ocular pathogens collected during the ARMOR surveillance study.","volume":"7","author":"Asbell","year":"2018","journal-title":"Ophthalmol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.ophtha.2017.05.012","article-title":"Update on the management of infectious keratitis.","volume":"124","author":"Austin","year":"2017","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099029","article-title":"Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.","volume":"9","author":"Beaumont","year":"2014","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5114\/ada.2018.62141","article-title":"Activity of antimicrobial peptides and conventional antibiotics against superantigen positive Staphylococcus aureus isolated from patients with atopic dermatitis.","volume":"35","author":"Blazewicz","year":"2018","journal-title":"Postepy Dermatol. Alergol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12868","DOI":"10.1073\/pnas.1717157115","article-title":"Antimicrobial resistance and the role of vaccines.","volume":"115","author":"Bloom","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-14-54","article-title":"Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the steroids for corneal ulcers trial show elevated resistance to fluoroquinolones.","volume":"14","author":"Borkar","year":"2014","journal-title":"BMC Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jamaophthalmol.2013.778","article-title":"Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.","volume":"131","author":"Borkar","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1133-3","article-title":"The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a paediatric intensive care unit.","volume":"15","author":"Ceccarelli","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01929-18","article-title":"Development of a broad-spectrum antimicrobial combination for the treatment of Staphylococcus aureus and Pseudomonas aeruginosa corneal infections.","volume":"63","author":"Chojnacki","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1128\/aac.37.11.2506","article-title":"Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin.","volume":"37","author":"Day","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/bjophthalmol-2012-301978","article-title":"The \u2019up-down\u2019 sign of acute ocular surface drug toxicity.","volume":"96","author":"Dua","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/02713680590968637","article-title":"A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs.","volume":"30","author":"Gordon","year":"2005","journal-title":"Curr. Eye Res."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00043","article-title":"Reassessing the host defense peptide landscape.","volume":"7","author":"Haney","year":"2019","journal-title":"Front. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000099269","article-title":"Bacterial infections of the cornea (Pseudomonas aeruginosa).","volume":"92","author":"Hazlett","year":"2007","journal-title":"Chem. Immunol. Allergy"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00722","article-title":"Cathelicidin-derived antimicrobial peptides inhibit zika virus through direct inactivation and interferon pathway.","volume":"9","author":"He","year":"2018","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2018.00204","article-title":"Antimicrobial peptides: interaction with model and biological membranes and synergism with chemical antibiotics.","volume":"6","author":"Hollmann","year":"2018","journal-title":"Front. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1167\/iovs.05-1649","article-title":"Multifunctional roles of human cathelicidin (LL-37) at the ocular surface.","volume":"47","author":"Huang","year":"2006","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1167\/iovs.07-0274","article-title":"Cathelicidin-deficient (Cnlp -\/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis.","volume":"48","author":"Huang","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12602-018-9444-5","article-title":"Antimicrobial activity of selected antimicrobial peptides against planktonic culture and biofilm of Acinetobacter baumannii.","volume":"11","author":"Jaskiewicz","year":"2018","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1093\/humrep\/dey315","article-title":"Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae.","volume":"33","author":"Kiattiburut","year":"2018","journal-title":"Hum. Reprod."},{"key":"B24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00018-014-1694-0","article-title":"Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis.","volume":"72","author":"Kolar","year":"2015","journal-title":"Cell Mol. Life Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions.","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1021\/ja0584875","article-title":"Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.","volume":"128","author":"Li","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00544","article-title":"The naturally occurring host defense peptide, LL-37, and its truncated mimetics KE-18 and KR-12 have selected biocidal and antibiofilm activities against Candida albicans, Staphylococcus aureus, and Escherichia coli in vitro.","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040795","article-title":"Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications.","volume":"23","author":"Manyi-Loh","year":"2018","journal-title":"Molecules"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1167\/iovs.04-0607","article-title":"The spectrum of antimicrobial peptide expression at the ocular surface.","volume":"46","author":"McIntosh","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1039\/C3RA42599A","article-title":"Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37.","volume":"3","author":"Mishra","year":"2013","journal-title":"RSC Adv<sup>\u2217<\/sup>"},{"key":"B31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/08927014.2017.1332186","article-title":"Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria.","volume":"33","author":"Mishra","year":"2017","journal-title":"Biofouling"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.03.004","article-title":"Human antimicrobial peptides in ocular surface defense.","volume":"61","author":"Mohammed","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s00018-007-6475-6","article-title":"Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.","volume":"64","author":"Mookherjee","year":"2007","journal-title":"Cell Mol. Life Sci."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00422","article-title":"Responses of Pseudomonas aeruginosa to antimicrobials.","volume":"4","author":"Morita","year":"2014","journal-title":"Front. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"9136","DOI":"10.1002\/chem.201801423","article-title":"Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa.","volume":"24","author":"Ng","year":"2018","journal-title":"Chemistry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00203-018-1485-3","article-title":"Colistin causes profound morphological alteration but minimal cytoplasmic membrane perforation in populations of Escherichia coli and Pseudomonas aeruginosa.","volume":"200","author":"O\u2019Driscoll","year":"2018","journal-title":"Arch. Microbiol."},{"key":"B37","author":"O\u2019Neill","year":"2016","journal-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. The Review on Antimicrobial Resistance."},{"key":"B38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1755-3768.2012.02489.x","article-title":"Profile of sight-threatening infectious keratitis: a prospective study.","volume":"91","author":"Otri","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007084","article-title":"Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens.","volume":"14","author":"Pletzer","year":"2018","journal-title":"PLoS Pathog."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01867","article-title":"Synthetic peptides to target stringent response-controlled virulence in a Pseudomonas aeruginosa murine cutaneous infection model.","volume":"8","author":"Pletzer","year":"2017","journal-title":"Front. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00064-16","article-title":"Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes.","volume":"30","author":"Poirel","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00065","article-title":"Pseudomonas aeruginosa: resistance to the max.","volume":"2","author":"Poole","year":"2011","journal-title":"Front. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.bbamem.2017.01.037","article-title":"LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.","volume":"1859","author":"Rajasekaran","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063641","article-title":"FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells.","volume":"8","author":"Ren","year":"2013","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1074\/jbc.M504327200","article-title":"Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action.","volume":"281","author":"Rosenfeld","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6284595","article-title":"Outcomes of infectious versus sterile perforated corneal ulcers after therapeutic penetrating keratoplasty in the United States.","volume":"2016","author":"Rush","year":"2016","journal-title":"J. Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijid.2005.03.005","article-title":"Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.","volume":"10","author":"Schina","year":"2006","journal-title":"Int. J. Infect. Dis."},{"key":"B48","first-page":"928","article-title":"The antimicrobial resistance containment and surveillance approach\u2013a public health tool.","volume":"82","author":"Simonsen","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"B49","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/ICU.0000000000000274","article-title":"Surgical management of corneal infections.","volume":"27","author":"Tuli","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.ophtha.2015.06.007","article-title":"Multidrug-resistant Pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes.","volume":"122","author":"Vazirani","year":"2015","journal-title":"Ophthalmology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/AAC.05637-11","article-title":"Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.","volume":"56","author":"Wang","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.bbamem.2014.01.016","article-title":"High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.","volume":"1838","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bbamem.2017.04.018","article-title":"Arginine-lysine positional swap of the LL-37 peptides reveals evolutional advantages of the native sequence and leads to bacterial probes.","volume":"1859","author":"Wang","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"B55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1444-0938.2010.00536.x","article-title":"Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.","volume":"94","author":"Willcox","year":"2011","journal-title":"Clin. Exp. Optom."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00661-18","article-title":"Characterization of host responses during Pseudomonas aeruginosa acute infection in the lungs and blood and after treatment with the synthetic immunomodulatory peptide IDR-1002.","volume":"87","author":"Wuerth","year":"2019","journal-title":"Infect. Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1021\/acsinfecdis.5b00114","article-title":"Glycopeptide antibiotic to overcome the intrinsic resistance of gram-negative bacteria.","volume":"2","author":"Yarlagadda","year":"","journal-title":"ACS Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jgar.2015.12.007","article-title":"Intracellular activity of a membrane-active glycopeptide antibiotic against methicillin-resistant Staphylococcus aureus infection.","volume":"5","author":"Yarlagadda","year":"","journal-title":"J. Glob. Antimicrob. Resist."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02190\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T07:10:11Z","timestamp":1568877011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02190\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,19]]},"references-count":58,"alternative-id":["10.3389\/fmicb.2019.02190"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.02190","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,19]]},"article-number":"2190"}}